Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Christopher L Gaenzle. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Christopher L Gaenzle har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
LU:XAL5000DAC10 / ICON Luxembourg Sarl | EVP, CAO & General Counsel | 0 |
US:SYNH / Syneos Health Inc - Class A | CAO, GC & Sec | 52 722 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Christopher L Gaenzle. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Christopher L Gaenzle som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-07-01 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Restricted Stock Unit |
D - Sale to Issuer | −14 008 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Restricted Stock Unit |
D - Sale to Issuer | −5 647 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Option (Right to Buy) |
D - Sale to Issuer | −17 114 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Option (Right to Buy) |
D - Sale to Issuer | −16 666 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Option (Right to Buy) |
D - Sale to Issuer | −37 500 | 0 | −100,00 | ||||
2021-07-01 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
D - Sale to Issuer | −34 500 | 0 | −100,00 | ||||
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −4 326 | 17 114 | −20,18 | ||||
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −18 958 | 37 500 | −33,58 | ||||
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −4 213 | 16 666 | −20,18 | ||||
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −692 | 34 500 | −1,97 | 169,75 | −117 467 | 5 856 375 |
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −12 114 | 35 192 | −25,61 | 169,41 | −2 052 233 | 5 961 877 |
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −13 391 | 47 306 | −22,06 | 168,06 | −2 250 491 | 7 950 246 |
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −1 300 | 60 697 | −2,10 | 167,40 | −217 620 | 10 160 678 |
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 4 326 | 61 997 | 7,50 | 103,30 | 446 876 | 6 404 290 | |
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 18 958 | 57 671 | 48,97 | 101,42 | 1 922 720 | 5 848 993 | |
2021-06-21 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 4 213 | 38 713 | 12,21 | 95,94 | 404 195 | 3 714 125 | |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −2 246 | 21 440 | −9,48 | ||||
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −2 188 | 20 879 | −9,49 | ||||
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −9 844 | 56 458 | −14,85 | ||||
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −500 | 34 500 | −1,43 | 167,49 | −83 745 | 5 778 405 |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −13 778 | 35 000 | −28,25 | 166,48 | −2 293 761 | 5 826 800 |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 2 246 | 48 778 | 4,83 | 103,30 | 232 012 | 5 038 767 | |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 2 188 | 46 532 | 4,93 | 95,94 | 209 917 | 4 464 280 | |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 9 844 | 44 344 | 28,53 | 101,42 | 998 378 | 4 497 368 | |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −1 984 | 23 686 | −7,73 | ||||
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −1 933 | 23 067 | −7,73 | ||||
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Options (Right to Buy) |
M - Exercise | −8 698 | 66 302 | −11,60 | ||||
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −202 | 34 500 | −0,58 | 168,83 | −34 104 | 5 824 635 |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −14 386 | 34 702 | −29,31 | 168,27 | −2 420 732 | 5 839 306 |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 1 984 | 49 088 | 4,21 | 103,30 | 204 947 | 5 070 790 | |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 1 933 | 47 104 | 4,28 | 95,94 | 185 452 | 4 519 158 | |
2021-06-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
M - Exercise | 8 698 | 45 171 | 23,85 | 101,42 | 882 151 | 4 581 243 | |
2021-06-03 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Restricted Stock Unit |
A - Award | 14 008 | 14 008 | |||||
2021-06-03 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Restricted Stock Unit |
M - Exercise | −2 823 | 5 647 | −33,33 | ||||
2021-06-03 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | −850 | 36 473 | −2,28 | 170,45 | −144 882 | 6 216 823 | |
2021-06-03 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
A - Award | 2 823 | 37 323 | 8,18 | ||||
2021-01-11 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | X | −3 136 | 34 500 | −8,33 | 130,04 | −407 805 | 4 486 380 |
2020-08-17 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Common Stock |
S - Sale | −1 364 | 37 636 | −3,50 | 102,88 | −140 328 | 3 871 992 | |
2020-06-03 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Stock Option (Right to Buy) |
A - Award | 25 670 | 25 670 | |||||
2020-06-03 |
|
4 | PRAH |
PRA Health Sciences, Inc.
Restricted Stock Unit |
A - Award | 8 470 | 8 470 | |||||
2020-03-05 | 3 | PRAH |
PRA Health Sciences, Inc.
Common stock |
78 000 | ||||||||
2020-03-05 | 3 | PRAH |
PRA Health Sciences, Inc.
Common stock |
78 000 | ||||||||
2020-03-05 | 3 | PRAH |
PRA Health Sciences, Inc.
Common stock |
78 000 | ||||||||
2018-01-30 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −912 | 52 722 | −1,70 | 40,75 | −37 164 | 2 148 422 | |
2018-01-23 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
S - Sale | X | −1 470 | 53 634 | −2,67 | 41,00 | −60 270 | 2 198 994 |
2018-01-23 |
|
4 | SYNH |
Syneos Health, Inc.
Class A Common Stock |
F - Taxes | −793 | 55 104 | −1,42 | 40,90 | −32 434 | 2 253 754 | |
2017-09-19 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 682 | 55 897 | −7,73 | 54,56 | −255 427 | 3 049 461 |
2017-09-19 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
F - Taxes | −4 245 | 60 579 | −6,55 | 54,85 | −232 838 | 3 322 758 | |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −23 668 | 0 | −100,00 | |||
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −14 200 | 0 | −100,00 | |||
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 733 | 0 | −100,00 | |||
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −11 834 | 64 824 | −15,44 | 58,46 | −691 756 | 3 789 287 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 636 | 76 658 | −2,09 | 59,60 | −97 509 | 4 568 970 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −10 198 | 78 294 | −11,52 | 59,10 | −602 692 | 4 627 097 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 23 668 | 88 492 | 36,51 | 16,06 | 380 108 | 1 421 182 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 733 | 64 824 | −6,80 | 58,67 | −277 704 | 3 803 483 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 467 | 69 557 | −11,98 | 58,47 | −553 507 | 4 066 789 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 14 200 | 79 024 | 21,91 | 10,06 | 142 852 | 794 981 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 733 | 64 824 | −6,80 | 58,35 | −276 180 | 3 782 610 |
2017-09-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 733 | 69 557 | 7,30 | 10,57 | 50 028 | 735 217 |
2017-08-14 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
A - Award | 11 475 | 11 475 | |||||
2017-08-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
M - Exercise | −13 575 | 0 | −100,00 | ||||
2017-08-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
M - Exercise | −13 920 | 0 | −100,00 | ||||
2017-08-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | 9 050 | 64 824 | 16,23 | ||||
2017-08-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | 9 280 | 55 774 | 19,96 | ||||
2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −956 | 46 494 | −2,01 | 58,55 | −55 974 | 2 722 224 |
2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −5 917 | 23 668 | −20,00 | |||
2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −5 917 | 46 494 | −11,29 | 58,28 | −344 872 | 2 709 903 |
2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 5 917 | 52 411 | 12,73 | 16,06 | 95 027 | 841 721 |
2017-07-05 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
F - Taxes | −867 | 47 450 | −1,79 | 58,50 | −50 720 | 2 775 825 | |
2017-04-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 733 | 4 733 | −50,00 | |||
2017-04-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 733 | 48 317 | −8,92 | 45,70 | −216 298 | 2 208 087 |
2017-04-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 733 | 53 050 | 9,80 | 10,57 | 50 028 | 560 738 |
2017-01-30 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
A - Award | 13 920 | 13 920 | |||||
2017-01-30 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 9 280 | 48 317 | 23,77 | ||||
2017-01-23 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 186 | 39 037 | −2,95 | 50,09 | −59 406 | 1 955 324 |
2017-01-23 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
F - Taxes | −1 077 | 40 223 | −2,61 | 50,55 | −54 442 | 2 033 273 | |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 733 | 9 466 | −33,33 | |||
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 733 | 9 466 | −33,33 | |||
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −5 917 | 29 585 | −16,67 | |||
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 733 | 41 300 | −10,28 | 51,91 | −245 676 | 2 143 759 |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 733 | 46 033 | 11,46 | 10,57 | 50 028 | 486 569 |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 733 | 41 300 | −10,28 | 51,89 | −245 605 | 2 143 140 |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 733 | 46 033 | 11,46 | 10,06 | 47 614 | 463 092 |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −100 | 41 300 | −0,24 | 52,25 | −5 225 | 2 157 925 |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −5 817 | 41 400 | −12,32 | 51,90 | −301 914 | 2 148 743 |
2017-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 5 917 | 47 217 | 14,33 | 16,06 | 95 027 | 758 305 |
2016-09-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 26 782 | 41 300 | 184,47 | ||||
2016-09-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 734 | 18 933 | −20,00 | |||
2016-09-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 734 | 14 518 | −24,59 | 43,14 | −204 234 | 626 336 |
2016-09-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 734 | 19 252 | 32,61 | 10,06 | 47 624 | 193 675 |
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −2 906 | 14 199 | −16,99 | |||
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −17 795 | 35 502 | −33,39 | |||
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 217 | 14 518 | −7,73 | 40,18 | −48 895 | 583 290 |
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −2 906 | 15 735 | −15,59 | 40,25 | −116 975 | 633 381 |
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 2 906 | 18 641 | 18,47 | 10,57 | 30 716 | 197 035 |
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −17 795 | 15 735 | −53,07 | 40,19 | −715 206 | 632 412 |
2016-07-12 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 17 795 | 33 530 | 113,09 | 16,06 | 285 788 | 538 492 |
2016-07-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
F - Taxes | −606 | 15 735 | −3,71 | 38,13 | −23 107 | 599 976 | |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −3 928 | 53 297 | −6,86 | |||
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −728 | 17 105 | −4,08 | |||
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −3 928 | 16 341 | −19,38 | 40,16 | −157 748 | 656 251 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 3 928 | 20 269 | 24,04 | 16,06 | 63 084 | 325 520 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −728 | 16 341 | −4,27 | 40,22 | −29 277 | 657 153 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 728 | 17 069 | 4,46 | 10,57 | 7 695 | 180 419 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −1 100 | 17 833 | −5,81 | |||
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −1 946 | 57 225 | −3,29 | |||
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 100 | 16 341 | −6,31 | 40,05 | −44 057 | 654 490 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 1 100 | 17 441 | 6,73 | 10,57 | 11 627 | 184 351 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 946 | 16 341 | −10,64 | 40,11 | −78 059 | 655 475 |
2016-06-16 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 1 946 | 18 287 | 11,91 | 16,06 | 31 253 | 293 689 |
2016-01-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Performance Restricted Stock Units |
A - Award | 13 575 | 13 575 | |||||
2016-01-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
A - Award | 4 022 | 4 022 | |||||
2016-01-21 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 9 050 | 16 341 | 124,13 | ||||
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 734 | 18 933 | −20,00 | |||
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −4 734 | 18 933 | −20,00 | |||
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −2 734 | 7 291 | −27,27 | 48,60 | −132 872 | 354 343 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −1 200 | 10 025 | −10,69 | 48,15 | −57 780 | 482 704 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −800 | 11 225 | −6,65 | 46,83 | −37 464 | 525 667 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 734 | 12 025 | 64,93 | 10,57 | 50 038 | 127 104 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −3 334 | 7 291 | −31,38 | 48,56 | −161 899 | 354 051 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −700 | 10 625 | −6,18 | 47,89 | −33 523 | 508 831 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −700 | 11 325 | −5,82 | 46,67 | −32 669 | 528 538 |
2016-01-04 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 4 734 | 12 025 | 64,93 | 10,06 | 47 624 | 120 972 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −6 534 | 7 291 | −47,26 | 45,13 | −294 906 | 329 072 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −8 169 | 13 825 | −37,14 | 35,36 | −288 831 | 488 811 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −11 193 | 28 401 | −28,27 | |||
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −13 992 | 23 667 | −37,15 | |||
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −119 | 21 994 | −0,54 | 45,10 | −5 367 | 991 995 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −4 540 | 22 113 | −17,03 | 44,70 | −202 915 | 988 341 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −147 | 26 653 | −0,55 | 45,10 | −6 630 | 1 202 130 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −5 676 | 26 800 | −17,48 | 44,70 | −253 689 | 1 197 826 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 11 193 | 32 476 | 52,59 | 10,06 | 112 602 | 326 709 |
2015-12-09 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 13 992 | 21 283 | 191,91 | 10,57 | 147 895 | 224 961 |
2015-09-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −7 743 | 39 594 | −16,36 | |||
2015-09-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
M - Exercise | X | −9 678 | 37 659 | −20,44 | |||
2015-09-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −7 743 | 7 291 | −51,50 | 41,13 | −318 470 | 299 879 |
2015-09-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 7 743 | 15 034 | 106,20 | 10,06 | 77 895 | 151 242 |
2015-09-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
S - Sale | X | −9 678 | 7 291 | −57,03 | 41,19 | −398 637 | 300 316 |
2015-09-01 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
M - Exercise | X | 9 678 | 16 969 | 132,74 | 10,57 | 102 296 | 179 362 |
2015-07-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Stock Option (Right to Buy Class A Common Stock) |
A - Award | 14 581 | 14 581 | |||||
2015-07-02 |
|
4 | INCR |
INC Research Holdings, Inc.
Class A Common Stock |
A - Award | 7 291 | 7 291 |